0001571049-15-005430.txt : 20150701
0001571049-15-005430.hdr.sgml : 20150701
20150701172907
ACCESSION NUMBER: 0001571049-15-005430
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150630
FILED AS OF DATE: 20150701
DATE AS OF CHANGE: 20150701
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: APPLIED DNA SCIENCES INC
CENTRAL INDEX KEY: 0000744452
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
IRS NUMBER: 592262718
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 50 HEALTH SCIENCES DRIVE
CITY: STONY BROOK
STATE: NY
ZIP: 11790
BUSINESS PHONE: 631-240-8800
MAIL ADDRESS:
STREET 1: 50 HEALTH SCIENCES DRIVE
CITY: STONY BROOK
STATE: NY
ZIP: 11790
FORMER COMPANY:
FORMER CONFORMED NAME: PROHEALTH MEDICAL TECHNOLOGIES INC
DATE OF NAME CHANGE: 20010504
FORMER COMPANY:
FORMER CONFORMED NAME: DCC ACQUISITION CORP
DATE OF NAME CHANGE: 19990211
FORMER COMPANY:
FORMER CONFORMED NAME: DATALINK CAPITAL CORP/TX/
DATE OF NAME CHANGE: 19980306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Liang Ming-Hwa Benjamin
CENTRAL INDEX KEY: 0001624582
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36745
FILM NUMBER: 15966220
MAIL ADDRESS:
STREET 1: C/O APPLIED DNA SCIENCES, INC.
STREET 2: 50 HEALTH SCIENCES DRIVE
CITY: STONY BROOK
STATE: NY
ZIP: 11790
4
1
t82683b-liang630.xml
FORM 4
X0306
4
2015-06-30
0
0000744452
APPLIED DNA SCIENCES INC
APDN
0001624582
Liang Ming-Hwa Benjamin
50 HEALTH SCIENCES DRIVE
STONY BROOK
NY
11790
0
1
0
0
Strategic Tech. Dev. Officer
Employee Stock Option (right to buy)
3.60
2015-06-30
4
D
0
166667
0
D
2015-06-30
Common Stock
166667
0
D
Employee Stock Option (right to buy)
3.60
2015-06-30
4
A
0
166667
0
A
2015-06-30
2020-06-30
Common Stock
166667
166667
D
The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from June 30, 2015 to June 30, 2020, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on July 1, 2010 and provided for vesting (i) with respect to 25% of the underlying shares on the original date of grant and (ii) with respect to the remaining underlying shares, ratably each anniversary thereafter until fully vested on the third anniversary of the original date of grant.
/s/ Beth Jantzen, Attorney-in-Fact
2015-07-01